Opens in a new tab
Tuesday, 17 November 2026
EVIDENCE. INTERPRETED.
Pharmacally

Disease & Drugs

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Disease & Drugs

1,785 stories · every one Fact-Checked
cervical cancerNew Drug Approval“Teal Wand Becomes First FDA Approved At Home Cervical Cancer Screening Device for High-Risk HPV – A Breakthrough for Women’s Health”On May 9, 2025, the U.S. Food and Drug Administration (FDA) approved the Teal Wand medical device.26 May 2025 · 7 min read
Fact-Checked
vaccine-bottle-syringe-held-by-doctor-with-glovesNew Drug Approval“England Rolls Out 5-Minute Subcutaneous Opdivo (Nivolumab) for 15+ Cancer Types, Enhancing Treatment Speed and Patient Convenience”Written by Priyanka Khamkar (M. Pharm) Pharmacology and Vikas Londhe M.Pharm, Pharmacology Source: Freepik.com The UK’s National Health Service (NHS)…24 May 2025 · 7 min read
Fact-Checked
Proptosis_and_lid_retraction_from_Graves’_DiseaseNew Drug ApprovalTepezza (Teprotumumab) A first Targeted Drug Receives Positive CHMP Opinion from EMA and Approval from MHRA to Treat Moderate to Severe Thyroid Eye Disease (TED) by Targeting IGF-1 ReceptorSource: Freepik.com Written by: Shakuntala Kawhale (Pharmacology The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…23 May 2025 · 9 min read
Fact-Checked
hands-patient-suffering-from-psoriasis_11zonNew Drug ApprovalQoyvolma: A More Affordable Biologic Option for Plaque Psoriasis and Inflammatory Diseases like Psoriatic Arthritis, Cohn’s Disease, and Ulcerative ColitisWritten by Rikesh Dighore (Pharmacology) and Soniya Hajare (Pharmacology) Source: Freepik.com The European Medicines Agency’s (EMA) Committee for Medicinal Product…22 May 2025 · 5 min read
Fact-Checked
SephienceNew Drug ApprovalEMA’s CHMP Recommends Sephience (sepiapterin) for Hyperphenylalaninaemia (HPA) in Adults and Children with Phenylketonuria (PKU)The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has accepted a positive opinion recommending the approval of Sephience (sepiapterin) for the…22 May 2025 · 6 min read
Fact-Checked
IgANNew Drug ApprovalFDA Grants Accelerated Approval to Novartis’ Vanrafia (Atrasentan): First and Only Endothelin-1 Receptor Blocker for Proteinuria Reduction in IgA Nephropathy (IgAN)The U.S. Food and Drug Administration (FDA) have granted accelerated approval to Novartis Pharmaceuticals Corporation for Vanrafia (atrasentan).19 May 2025 · 7 min read
Fact-Checked
freepik__an-artistic-abstract-rendering-of-a-neuromuscular-__67190New Drug ApprovalFDA Approves Imaavy (nipocalimab-aahu), a Neonatal Fc Receptor (FcRn) Blocker, Offering New Hope for People Living with Generalized Myasthenia Gravis (gMG)Written by Priya Bhaware (M.Pharm. Pharmacology) Source: Freepik.com The Food and Drug Administration approved Imaavy (Nipocalimab-aahu) for the treatment of…19 May 2025 · 6 min read
Fact-Checked
portrait-man-suffering-from-schizophrenia_11zonNew Drug ApprovalFDA Approval of Atzumi Marks a New Era in Migraine Treatment with SMART MucoAdhesive DeliveryThe U.S. Food and Drug Administration (FDA) have approved Atzumi (dihydroergotamine mesylate) nasal powder for the acute treatment of adult migraine with or without aura, marking a major…19 May 2025 · 7 min read
Fact-Checked
close-up-examination-with-tongue-depressor_11zonNew Drug ApprovalFDA Approves PD-1 Inhibitor Penpulimab-kcqx for Advanced Nasopharyngeal Carcinoma (NPC)In the landmark development, U.S. Food and Drug Administration have approved innovative PD-1 monoclonal antibody, penpulimab-kcqx, in combination with cisplatin or carboplatin and gemcitabine for the initial treatment…17 May 2025 · 6 min read
Fact-Checked
3d-medical-background-with-virus-cells-dna-strand_11zonNew Drug ApprovalFDA Approves Zevaskyn (Prademagene Zamikeracel) for Recessive Dystrophic Epidermolysis Bullosa (RDEB): Gene Therapy Targets COL7A1 Gene and Boosts Type VII Collagen (C7)For the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), the FDA has approved Zevaskyn (prademagene zamikeracel), the first autologous cell-based gene therapy.17 May 2025 · 6 min read
Fact-Checked
freepik__a-microscopic-view-of-ovarian-cancer-cells-stained__53956New Drug ApprovalFDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack for KRAS-Mutated Low Grade Serous Ovarian Cancer (LGSOC) Targeting RAS/MAPK PathwayIn a significant progress in ovarian cancer treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Avmapki Fakzynja Co-Pack (avutometinib capsules and defactinib tablets)…16 May 2025 · 6 min read
Fact-Checked
freepik__the-style-is-candid-image-photography-with-natural__20753New Drug ApprovalJapan First-in-the-World to approve Elevidys (Delandistrogene Moxeparvovec), one-of-the Costliest Gene Therapy Drug for Duchenne Muscular Dystrophy (DMD) in Children less than 4 years of ageIn a groundbreaking step forward for genetic medicine, Japan has become the first country in the world to approve the use of Elevidys (delandistrogene moxeparvovec), a gene therapy…15 May 2025 · 6 min read
Fact-Checked
Page 144 of 149